Sharpening the Target: Fibroblast Activation Protein Inhibitor Imaging in Dilated Cardiomyopathy
- PMID: 40908070
- DOI: 10.1016/j.jcmg.2025.06.016
Sharpening the Target: Fibroblast Activation Protein Inhibitor Imaging in Dilated Cardiomyopathy
Keywords: dilated cardiomyopathy, fibroblast activation protein inhibitor, positron emission tomography.
Conflict of interest statement
Funding Support and Author Disclosures Dr Pelletier-Galarneau is supported by a salary award from the Fonds de recherche du Québec–Santé; has received a research grant from Jubilant Radiopharma; and is a consultant for Pfizer and Jubilant Radiopharma. Dr Regis has reported that she has no relationships relevant to the contents of this paper to disclose.
Publication types
LinkOut - more resources
Full Text Sources